TABLE 5

Clinical Outcomes a Median of 2.5 Years After Initial Ablation Using Suppressed Thyroglobulin of Less Than 2 ng/mL and Stimulated Thyroglobulin of Less Than 10 ng/mL to Define NCED

ParameterNCEDClinical recurrencePersistent diseaseTB uptake OnlyP
THW (n = 74)62.2% (46)6.8% (5)24.3% (18)6.8% (5)0.10
rhTSH (n = 320)76.3% (244)3.8% (12)15.9% (51)4.1% (13)
Total (n = 394)73.6% (290)4.3% (17)17.5% (69)4.6% (18)
  • TB = thyroid bed.